Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - LONG-TERM DEBT
Long-term Debt OCX - OncoCyte Corporation
2.2 M
LAST VALUE
-21.15%
2 YEAR CAGR
32.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR